Therapeutic-Category Medication Burden Among Adults With Treated Diabetes in the Health Survey for England 2022
Therapeutic-Category Medication Burden bei Erwachsenen mit behandeltem Diabetes in der Health Survey for England 2022
SN Comprehensive Clinical Medicine · 05.10.2026 · 8 (1)
DOI: 10.1007/s42399-026-02755-4 ↗Auf einen Blick
In einer Querschnittsanalyse der HSE 2022 erfüllten 40,8 % der Erwachsenen mit behandeltem Diabetes die Schwelle von ≥ 3 therapeutischen Kategorien. Höhere Werte zeigten sich in einigen Alters- und Deprivationsgruppen.
Fragestellung
Wie ist die therapeutische Kategorienlast bei Erwachsenen mit behandeltem Diabetes in der HSE 2022 verteilt, und welche soziodemografischen Muster bestehen?
Methode
Querschnittsdaten der HSE 2022; Erwachsene ≥ 16 Jahre mit Diabetes und antidiabetischer Behandlung nach Nurse-Visit; ungewichtete Analysen, logistische Regression zu Alter, Geschlecht und Deprivation.
Ergebnisse
N = 262; 107/262 (40,8 %; 95 %-KI 34,8–47,1) erfüllten ≥ 3 Kategorien. Alter 55–64 vs. < 55: aOR 3,07 (95 %-KI 1,12–8,46); stärkste Deprivation vs. geringste: aOR 3,21 (95 %-KI 1,38–7,47).
Einschränkungen
Ungewichtete Analysen beschreiben die ausgewählte Stichprobe, nicht die Prävalenz in der Bevölkerung. Schätzungen zu Behandlungsgruppen waren unpräzise, besonders bei Insulin-only-Nutzern.
Schlussfolgerung der Autor:innen
In dieser HSE-Nurse-Visit-Stichprobe erfüllten etwa zwei von fünf Teilnehmenden die Studie-spezifische Schwelle von ≥ 3 Kategorien. Es zeigten sich höhere Werte in einigen Alters- und Deprivationsgruppen.
Kernaussagen
- 40,8 % erfüllten die Schwelle von ≥ 3 Kategorien
- Höhere Odds bei 55–64 Jahren und in der stärksten Deprivation
- Keine klaren Unterschiede nach Diabetes-Behandlungsmodalität
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift SN Comprehensive Clinical Medicine, online erschienen am 05.10.2026. Verfasst von Duaa Abdullah Bafail und 1 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Polypharmacy is commonly defined using counts of individual medicines, but definitions vary and category-based measures capture a different construct. We described therapeutic-category medication burden and associated sociodemographic patterns among adults with treated diabetes in the Health Survey for England (HSE) 2022 nurse-visit analytical sample.
Methods
Cross-sectional HSE 2022 data included adults (≥ 16 years) who completed the nurse visit, reported diabetes, and received antidiabetic treatment ( N = 262). Medication burden was the number of six broad therapeutic categories with ≥ 1 prescribed medicine taken in the past 7 days; the primary outcome was ≥ 3 categories. Analyses were unweighted and describe the selected analytical sample rather than population-level prevalence. Logistic regression examined age, sex and area deprivation; treatment-modality analyses included 256 participants with classifiable treatment status. Sensitivity analyses examined stricter thresholds of ≥ 4 and ≥ 5 categories and alternative outcome definitions excluding antibacterial medications and excluding both antibacterial medications and NSAIDs.
Results
Overall, 107/262 participants (40.8%; exact 95% CI 34.8–47.1) met the ≥ 3-category threshold. The 55–64-year group had higher adjusted odds than the < 55 group (aOR 3.07, 95% CI 1.12–8.46), and the most deprived quintile had higher odds than the least deprived quintile (aOR 3.21, 95% CI 1.38–7.47); however, overall Wald tests for age ( p = 0.128) and deprivation ( p = 0.089) were not statistically significant. No statistically significant differences were detected across treatment groups (overall Wald p = 0.824), and estimates were imprecise, particularly for insulin-only users. Using stricter thresholds, 11.1% (29/262; 95% CI 7.5–15.5) met the ≥ 4-category threshold and 3.4% (9/262; 95% CI 1.6–6.4) met the ≥ 5-category threshold. Excluding antibacterial medications had little effect on the ≥ 3-category proportion (40.5%), whereas excluding both antibacterial medications and NSAIDs reduced it to 35.9%.
Conclusions
In this HSE nurse-visit analytical sample, about two in five participants met the study-specific ≥ 3-category medication-burden threshold. Higher burden was observed in some age and deprivation groups, while no clear differences were detected across diabetes treatment modalities. The findings highlight the breadth of therapeutic-category exposure among adults with treated diabetes and the potential value of comprehensive medication review that considers both clinical and socioeconomic context.
Zitieren
APA
Bafail, D. A., & Adebisi, Y. A. (2026). Therapeutic-Category Medication Burden Among Adults With Treated Diabetes in the Health Survey for England 2022. SN Comprehensive Clinical Medicine, 8(1). https://doi.org/10.1007/s42399-026-02755-4
Vancouver
Bafail DA, Adebisi YA. Therapeutic-Category Medication Burden Among Adults With Treated Diabetes in the Health Survey for England 2022. SN Comprehensive Clinical Medicine. 2026;8(1). doi:10.1007/s42399-026-02755-4
BibTeX
@article{Bafail2026,
author = {Bafail, Duaa Abdullah and Adebisi, Yusuff Adebayo},
title = {Therapeutic-Category Medication Burden Among Adults With Treated Diabetes in the Health Survey for England 2022},
journal = {SN Comprehensive Clinical Medicine},
year = {2026},
volume = {8},
number = {1},
doi = {10.1007/s42399-026-02755-4}
}
EUVIMED